HDAC6 and pancreatic adenocarcinoma: Kaplan-Meier survival curves indicated that pancreatic adenocarcinoma patients presenting high HDAC-6 expression had significantly longer survival times compared to those with low expression (Fig. 2d, Table 2, log-rank test, p = 0.0113).